The ICMJE authorship criteria are four cumulative conditions — substantial contribution, drafting or critical revision, final approval, and accountability — that a journal-listed author must meet in full. They decide who qualifies for the byline, but they say nothing about what each named author actually did, which is why a growing number of journals now pair the ICMJE test with a granular CRediT contributor-role declaration.
The ICMJE authorship criteria are the International Committee of Medical Journal Editors’ four-part definition of authorship, first published in the ICMJE Recommendations and now the de facto global standard referenced by COPE, most biomedical journals, and many university research-integrity offices.
What are the four ICMJE authorship criteria?
The ICMJE recommends that authorship rest on four criteria, all of which must be met — not a majority. An individual must have made substantial contributions to conception, design, or data work; drafted or critically revised the manuscript; given final approval of the published version; and agreed to be accountable for its accuracy and integrity.
- Criterion 1 — Substantial contribution: conception or design of the work, or acquisition, analysis, or interpretation of data.
- Criterion 2 — Drafting or critical revision: writing the manuscript or reviewing it critically for important intellectual content.
- Criterion 3 — Final approval: sign-off on the exact version submitted for publication.
- Criterion 4 — Accountability: agreement to answer for the accuracy and integrity of any part of the work, including parts done by co-authors.
The ICMJE is explicit that these criteria are not a filter for excluding deserving colleagues: anyone who meets criterion 1 must get the opportunity to participate in drafting, review, and approval, so they can also satisfy criteria 2–4. Funding acquisition, general supervision, and technical or language editing — on their own — do not qualify a contributor for authorship; those belong in the acknowledgements, not the byline.
A newer addition addresses generative AI directly: under the current ICMJE Recommendations, journals must require disclosure of AI-assisted technology use, and chatbots such as ChatGPT cannot be listed as authors, because they cannot be held accountable for accuracy and integrity under criterion 4.
Why does meeting the criteria still produce authorship disputes?
The four-point test is qualitative, self-reported, and adjudicated by the author group itself — the ICMJE states explicitly that it is “the collective responsibility of the authors, not the journal” to determine who qualifies, and that editors should not arbitrate authorship conflicts. That design leaves real gaps in practice.
- The biostatistician who never drafts. A statistician runs the primary analysis (clearly criterion 1) but is not invited to write or revise the manuscript, so criterion 2 is never offered to them — despite the ICMJE’s own instruction that anyone meeting criterion 1 should get that opportunity. This is one of the most common authorship grievances reported to COPE.
- Guest and honorary authorship. A senior figure who supervised the lab, but did not contribute intellectually to conception, analysis, drafting, or revision, is added to the byline for prestige or funding-renewal reasons. COPE’s authorship guidance identifies two minimum requirements across authorship definitions — a substantial contribution and accountability — and honorary authors typically fail both.
- Ghost authorship. A medical writer or industry statistician does the drafting and analysis but is left off the byline entirely, often in industry-funded clinical trials, obscuring who is actually accountable for the reported results.
- Large multi-author consortia. When hundreds of contributors work on a single dataset or trial, the ICMJE recommends the group decide authorship before the work starts — but retrospectively verifying that every named individual met all four criteria, including final approval, becomes practically unenforceable at scale.
In each case, the pass/fail structure of the ICMJE test cannot show a reader, an editor, or a research-integrity investigator which specific task a disputed author did or didn’t do. That is the exact gap CRediT was built to close.
How do CRediT contributor roles add the missing granularity?
CASRAI originated the CRediT contributor role taxonomy in 2014 as a structured vocabulary of contribution types. The standard is now stewarded by NISO as ANSI/NISO Z39.104-2022, and it defines 14 discrete roles — Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, and Writing – review & editing.
Where the ICMJE test asks a single binary question — author or not — CRediT asks a descriptive one: which of these 14 tasks did this named contributor actually perform, and can more than one person share a role. Journals across Elsevier, Cell Press, PLOS, and Frontiers now request a CRediT statement alongside (not instead of) an ICMJE-compliant author list, and several also publish CRediT contributions for non-author acknowledged contributors.
| Dimension | ICMJE authorship criteria | CRediT contributor roles |
|---|---|---|
| Function | Threshold test: qualifies for the byline or not | Descriptive vocabulary: records specific tasks performed |
| Structure | 4 cumulative, all-or-nothing criteria | 14 non-exclusive, combinable roles |
| Who it covers | Named authors only | Authors and non-author contributors alike |
| Steward | International Committee of Medical Journal Editors | NISO (ANSI/NISO Z39.104-2022), originated by CASRAI |
| Resolves guest/ghost authorship? | In theory, no — self-adjudicated and unverifiable at the criteria level | Makes the mismatch visible: a “Writing” credit with no “Investigation” or “Formal analysis” role is a red flag |
The complementary use matters most in the disputed scenarios above. A CRediT statement that lists a senior author under Supervision only — with no Conceptualization, Investigation, Formal analysis, or Writing role — gives an editor or institutional investigator concrete evidence to test against the ICMJE’s four criteria, something a bare byline never could.
Answer-first: common authorship questions
What are the criteria for authorship in the ICMJE?
The ICMJE requires all four criteria to be met: substantial contribution to conception, design, or data work; drafting or critical revision of the manuscript; final approval of the published version; and accountability for the work’s accuracy and integrity. Meeting only some criteria means acknowledgement, not authorship.
What are the five criteria for authorship?
Some sources describe “five criteria” by splitting the ICMJE’s fourth criterion — accountability — into two parts: taking responsibility for the work and confirming its integrity. The ICMJE’s own text remains four official criteria; the five-part version is a restatement, not a competing standard.
What are the minimum requirements for authorship?
COPE identifies two minimum requirements common to authorship definitions across disciplines: making a substantial contribution to the work, and being accountable for the work and its published form. These map directly onto ICMJE criteria 1 and 4.
What are the guidelines for authorship?
Authorship guidelines set who can be named on a publication and what they must do to earn that status. The dominant biomedical framework is the ICMJE’s four-criteria test, supplemented in practice by CRediT contributor-role statements and journal-specific policies aligned with COPE guidance.
What this means for journals, institutions, and researchers
For editors, ICMJE and CRediT serve different stages of one workflow: ICMJE decides the byline, CRediT documents the record. Requiring both at submission gives research-integrity offices a verifiable trail when a dispute later reaches them, since the ICMJE explicitly directs unresolved conflicts to the researchers’ institution, not the journal.
For research administrators, a documented CRediT statement is often the fastest way to evidence individual contribution for funder and promotion-committee requirements, independent of authorship order.
For early-career researchers and biostatisticians, raising criterion-2 access early — asking to review and comment on a draft — is the practical way to convert a CRediT-documented “Formal analysis” role into full ICMJE-qualifying authorship before submission, not after a dispute arises.
Where authorship attribution is heading
Neither framework is static. The ICMJE continues to revise its recommendations — most recently to address AI-assisted technology disclosure — and CRediT’s stewardship under NISO opens a formal maintenance path for role definitions as research practice evolves. The direction of travel is layering, not replacement: a qualitative gate for who is accountable, and a structured record of who did what.
Journals, funders, and institutions that adopt both the CRediT taxonomy and ICMJE-aligned authorship policies give readers, editors, and integrity investigators the clearest possible picture of a paper’s provenance — something the four-point test was never designed to provide on its own. For definitions of individual roles, see the CRediT roles reference and the broader research-administration dictionary.
Leave a Reply